IQ-AI Ltd
OTC:IQAIF
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| JE |
|
IQ-AI Ltd
LSE:IQAI
|
1.2m GBP |
Loading...
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
Loading...
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
29.7B USD |
Loading...
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
13.6B AUD |
Loading...
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.2T JPY |
Loading...
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD |
Loading...
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD |
Loading...
|
|
| SE |
|
Sectra AB
STO:SECT B
|
36.7B SEK |
Loading...
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
23.1B CNY |
Loading...
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
Loading...
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
240.1B INR |
Loading...
|
Market Distribution
| Min | -1.2% |
| 30th Percentile | 0.4% |
| Median | 0.6% |
| 70th Percentile | 1% |
| Max | 1 871.3% |
Other Profitability Ratios
IQ-AI Ltd
Glance View
IQ-AI Ltd. is a holding company, which engages in the provision of clinical treatments to patients in the field of medical imaging diagnostics. The firm provides health care technology solutions to the artificial intelligence (AI) medical imaging market. Through its subsidiary, StoneChecker Software Ltd, It offers medical imaging software for urolithiasis that analyses and presents stone metrics, including stone size, volume, density, skin to stone distance, and stone architecture through TexRAD analysis within the healthcare information technology (IT) systems. Through its subsidiary, Imaging Biometrics, LLC, It specializes in the design and manufacture of visualization tools, the application of machine learning and AI software solutions, and the development and clinical testing of imaging endpoints and biomarkers. Its portfolio consists of IB Neuro and IB Diffusion that are used in treatment of brain tumors, strokes and pathologies.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for IQ-AI Ltd is 98.8%, which is above its 3-year median of 98.5%.
Over the last 3 years, IQ-AI Ltd’s Gross Margin has increased from 97.9% to 98.8%. During this period, it reached a low of 96.7% on Dec 31, 2021 and a high of 99.7% on Dec 31, 2022.
